Home | Survey | Payment| Talks & Presentations | Job Opportunities
Journals   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Chinese Journal of Lung Cancer
1009-3419
2007 Issue 2
zhong guo fei ai za zhi gao yue
..............page:封3-封4
zuo zhe bian zhe du zhe
..............page:162
qi shi xiao xi
..............page:137,151
guo chan ji xi ta bin lian he shun bo zhi liao 36 li lao nian wan qi fei xiao xi bao fei ai de lin chuang guan cha
he jian ping ; xu jian hui ; zuo xi ; yi cheng ; li lu ; ren li ; luo de yun ; hou mei ; bi feng ; xie ming ying
..............page:127
fei ju xi bao ai duo fa zhuan yi yi li bao gao bing wen xian fu xi
wu xing zuo ; li zuo ; yang yi ; yang cheng gang
..............page:106
yu ce fang she xing fei bing fa sheng de zao qi zhi biao yan jiu
zhao yan hai ; li zhi ping ; xu yong
..............page:160-162
di ji liang hua liao zai zhong wan qi fei ai zhi liao zhong de ying yong
yang he ping ; gong liang
..............page:157-159
fei ai gan xi bao de yan jiu xian zhuang
zhong hua ; han bao hui
..............page:155-156
Clinical characteristics and prognosis analysis of pulmonary carcinosarcoma (a report of 48 cases)
XU Qinghua;ZHOU Caicun;NI Jian;ZHOU Songwen;JIANG Gening;DING Jiaan
..............page:148-151
A randomized study comparing topotecan plus cisplatin versus etoposide plus carboplatin for previously untreated small cell lung cancer
ZHANG Shucai;WANG Jinghui;WANG Qunhui;ZHANG Hui;HU Fanbin;YANG Xinjie;FAN Xiaofang;WANG Haiyong;GU Yanfei;LI Xi
..............page:144-147
Clinical and prognostic significance of serum MMP-9, endostatin and VEGF in patients with advanced non-small cell lung cancer
LI Xuebing;LI Baolan;LAI Baitang;ZHANG Xinyong;GE Qiping;ZHAN Xiuping;WANG Yue;ZHU Yunzhong
..............page:138-140
Prognostic value of survivin and cyciooxygenase-2 expression in non-small cell lung cancer: a tissue microarray analysis
SONG Na;ZHAO Zhilong;LIU Yunpeng;SUN Lihua;ZHANG Lin;HU Xuejun
..............page:133-137
Variation of mitochondrial DNA noncoding region in lung cancer cell lines
SUN Hengwen;HU Yide
..............page:124-127
Construction of antisense Sip2 gene and its effects on growth and proliferation of lung cancer cell lines
SU Lei;ZHANG Jian;WEI Xiuqin;ZHI Xiuyi;XU Qinsheng;LIU Zhihua
..............page:120-123
Clinicopathological features of inflammatory myofibroblastic tumors of the lung
YANG Hong;XIE Rongqing;XIAO Jian;ZHANG Shangfu
..............page:116-119
Risk factor of brain metastasis in locally advanced non-small cell lung cancer after surgery
YE Xiong;WANG Siyu;OU Wei;ZENG Zhifan;LIN Yongbin;ZHANG Binbin
..............page:111-115
Survival analysis of completely resected stage ⅢB non-small cell lung cancer
WEI Weidong;WANG Siyu;LIN Peng;LI Xiaodong;WEN Zhesheng;RONG Tiehua
..............page:107-110
Retrospective analysis of screening results of lung cancer cases among occupational population at high risk of lung cancer
FAN Yaguang;JIANG Yong;CHANG Runsheng;YAO Shuxiang;HU Ping;QIAO Youlin
..............page:102-106
Expression and clinicopathological significance of OPN and CD44v6 in lung cancer
YANG Yanjuan;CHENG Deyun;LI Xixia;FANG Xun
..............page:98-101
Construction, expression and purification of kinase suppressor of Ras, KSR
XIAO Wen;ZHOU Qinghua;WANG Yanping;ZHU Wen;CHEN Xiaohe;YANG Xueqin;ZHU Daxing
..............page:93-97
Expression of survivin and PCNA in lung cancer cells induced by Gejiu mineral powder
LIANG Rui;JIN Kewei;WANG Zhiqiang;ZHAO Zuohui;WANG Fang;GAO Qian;RUAN Yonghua
..............page:83-87